Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, December 26, 2024.
CRISPR Therapeutics AG - Common Shares (NASDAQ:CRSP)
Long-Term Downtrend (-90) - CRSP is in a strong downtrend that is likely to continue. While CRSP is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CRSP?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRSP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRSP
The long-term trend has been DOWN since Dec 13th, 2024 at 43.4200
The intermediate-term trend has been DOWN since Nov 21st, 2024 at 46.3000
The short-term trend has been DOWN since Dec 10th, 2024 at 49.0027
Smart Scan Analysis for CRSP
Based on our trend formula, CRSP is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 40.480 | 41.015 | 39.800 | 40.930 | +0.450 |
| Prev. Close | Volume | Bid | Ask | Time |
| 40.940 | 718880 | 2024-12-24 12:59:57 |
| Year High | 73.9 | Year High Date | 2018-05-24 |
| Year Low | 23.01 | Year Low Date | 2018-01-03 |
| 52wk High | 91.1 | 52wk High Date | 2024-02-22 |
| 52wk Low | 39.41 | 52wk Low Date | 2024-12-20 |
| Average Volume | 1,842,360 | Shares Outstanding | 85,353 |
| Market Cap | 2,616M | Assets | 225,613,000M |
| Liabilities | 316,472,000M | P/E Ratio | -8.27030000 |
| Volatility | 74.22 |